Douglas Corley is a healthcare entrepreneur based in Beijing. He is the CEO and founder of DHB Global and CEO of Alaunius Technologies. DHB Global is a biotech commercialization platform. It specializes in bringing innovative healthcare solutions to their next stage of growth. The company helps U.S. and European companies gain a foothold in China. Its work helps clients raise capital, find business partners and build in-country facilities.DHB also works with Chinese pharmaceutical and medical device companies to provide life-saving medicines to Belt and Road partners in the Middle East and North Africa, Latin America and Africa. Alaunius Technologies is a blockchain-powered health-support platform that provides electronic health records and biomarkers to enable patients to receive accurate medication. Douglas has seven years of experience as a researcher in China's top biomedical laboratories and hospitals (CAS, 301 Hospital and Beijing Hospital). He was nominated as a member of the United Nations Development Program's Greater China Innovation Council. He serves as a digital health and biotech advisor to several investment groups and NGOs: Endeavour Global, Antler and Schwarzman Scholars. Douglas is a community member of the World Economic Forum. As founder of the Druid Collective program, he helps other startups bring breakthrough science from the lab to real-world impact. Douglas grew up in Omaha, Nebraska and earned dual degrees in Biomedical Sciences and Analytic Phil